Immunocure Inc. is a drug discovery CRO that specializes in Drug Discovery and Development research using cutting edge AI and Computational chemistry. With a head office in the USA and a research unit in India, the company was founded by Dr. Ravi Kumar Muttineni, who brings over a decade of drug discovery experience, including time at Schrodinger. Established in 2019, Immunocure Inc. serves several clients in the USA, including a prestigious university, and assists organizations in their drug discovery projects based on milestones such as target validation, hit identification, hit to lead discovery, and lead optimization. As drug discovery experts, Immunocure Inc. is well-equipped to help organizations with their drug discovery needs.
Show More